advertisement
Abstract #14436 Published in IGR 8-4
A comparison of latanoprost monotherapy with a combination therapy of timolol/dorzolamide in patients with primary open-angle glaucoma
Caca I; Simsek H; Unlu K; Ari S; Keklikci UAnnals of ophthalmology (Skokie, Ill.) 2006; 38: 111-115
We compared latanoprost monotherapy therapy with timolol/dorzolamide in patients with primary open-angle glaucoma to evaluate the effects on intraocular pressure (IOP) and occurrence of adverse events. IOP and topical side effects were evaluated at the begining, first, and third months. Mean IOP was decreased at the third month. The most common side effect was hyperemia (43.6%). We concluded that latanoprost reduces IOP better than fixed combination and its topical side effects are tolerable.
Dr. Prof. I. Caca, Dicle Universitesi Tip Fakultesi, Goz Hastaliklari ABD, 21280 Diyarbakir, Turkey
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)
11.5.2 Topical (Part of: 11 Medical treatment > 11.5 Carbonic anhydrase inhibitors)
11.3.4 Betablocker (Part of: 11 Medical treatment > 11.3 Adrenergic drugs)
